Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Verrica Pharmaceuticals Receives Complete Response Letter From The FDA Identifying Deficiencies At A Facility Of A Contract Manufacturer For Its New Drug Application For VP-102 For The Treatment Of Molluscum Contagiosum

Verrica Pharmaceuticals Inc. (the "Company") (NASDAQ:VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and

VRCA